Full-Time

Neurology Sales Manager

Alzheimer’s

Posted on 11/23/2025

GE Healthcare

GE Healthcare

1-10 employees

Imaging, monitoring, and healthcare IT solutions

Compensation Overview

$158.4k - $237.6k/yr

San Francisco, CA, USA + 4 more

More locations: Austin, TX, USA | Los Angeles, CA, USA | Chicago, IL, USA | Phoenix, AZ, USA

Hybrid

Category
Sales & Account Management (2)
,
Required Skills
Sales
Salesforce
Requirements
  • 5+ years of consultative sales experience including strategic selling and negotiation
  • Collaborative approach to working cross-functionally and building teams
  • Demonstrated strategic thinking, account planning, funnel management, analytical, data-driven and forecasting skillsets
  • Willingness to travel 20-50% for customer meetings, conferences, team meetings, and sales team member development
Responsibilities
  • Accountable to achieve the quarterly and yearly Operating Plan for the Region (orders, sales, contribution margin, base costs, operating margin and cash where applicable), together with customer satisfaction and retention
  • Responsible to set appropriate Operating Plan targets based on the market potential, for the members of your team. Provide business overviews to leadership to assess progress to goals.
  • Understand the dynamic PET Amyloid space and be a trusted advisor to help customers navigate new amyloid PET imaging marketplace
  • Understand and analyze market dynamics and competition to develop business opportunities for your region. Develop and execute go-to-market strategy in conjunction with cross-functional team in order to cover the prioritized potential within the geography
  • Understand the different call points required for success and the prioritization of these calls points (imaging centers, referring physicians, and pharmacy partners)
  • Understand and leverage the value of providing referring physician education and office-based resources and how this impacts referrals into preferred imaging centers using GEHC’s PET Amyloid product Vizamyl
  • Collaborate with pharmacy partners to drive mutually beneficial activities to support delivery of Vizamyl and create a high-quality customer experience
  • Manage relationships with key customers and accounts that require executive level communication
  • Lead strategy, actively participate in, and help close large or critically strategic opportunities
  • Provide Voice of Customers and identify opportunities of continuous improvement
  • Attend key conferences to represent the GEHC PET Amyloid product Vizamyl
  • Drive collaboration, community, and one GEHC mindset with counterparts and their sales teams to create a positive customer experience and support growth across GEHC portfolio
  • Attract, retain, educate and develop world-class commercial talents to execute on Zone Go-to-market strategy; drive performance management within the team, providing a regular operating mechanism of feedback, coaching, and development; work with the team and drive employee engagement activities to ensure retention across the zone, recognizing success, sharing best practices, providing exposure to people within the team with senior leaders within the region, products and modalities
  • Coach and drive adoption of sales teams utilization of GEHC CRM Salesforce to create and manage opportunities
  • Responsible to communicate, execute and leverage the Variable Sales Incentive plans with their teams and ensure all team members utilize the required sales systems to create pipeline visibility and accurate forecasting
Desired Qualifications
  • Molecular imaging prior experience
  • Healthcare experience, specialty in neurology
  • At least 2 years of prior sales management experience
  • Direct and/or Indirect management experience; managing in a matrix organization
  • Strong oral and written communication skills. Strong interpersonal and leadership skills. Demonstrated ability to analyze and resolve problems. Demonstrated ability to lead programs / projects. Ability to document, plan, market, and execute programs. Established project management skills

GE Healthcare Systems provides medical technologies and digital infrastructure to improve diagnosis, treatment, and monitoring of patients. Its products include imaging systems, mobile diagnostic devices, patient monitoring tools, and healthcare IT software that work together as hardware, software, and services to support hospitals, clinics, and researchers. The company differentiates itself with a large, integrated ecosystem, strong focus on AI analytics, and a global service network backed by substantial R&D investment. Its goal is to improve patient outcomes and the efficiency of healthcare delivery by enabling accurate diagnoses, effective treatments, and scaled operations.

Company Size

1-10

Company Stage

IPO

Headquarters

Chicago, Illinois

Founded

1892

Simplify Jobs

Simplify's Take

What believers are saying

  • $2.3B Intelerad acquisition boosts cloud imaging amid $5.1B Q1 2026 revenue.
  • DeepHealth AI partnership lifts breast cancer detection 21% globally.
  • $21.8B backlog and supply chain shifts sustain 3-4% organic growth.

What critics are saying

  • Siemens Cios Alpha erodes CT share with superior resolution by Q2 2027.
  • Canon Vantage Galan captures MRI contracts 20-30% cheaper in 6-12 months.
  • FTC probe forces Intelerad divestitures, costing $300-500M by Q1 2027.

What makes GE Healthcare unique

  • GE HealthCare's four divisions span imaging, ultrasound, patient care, and pharmaceutical diagnostics.
  • Bangalore's $50M R&D center drives innovations across 100+ countries.
  • Photonova Spectra's Deep Silicon detectors enable 8-bin energy resolution CT imaging.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

401(k) Retirement Plan

401(k) Company Match

Tuition Reimbursement

Relocation Assistance

Company News

The Associated Press
Apr 9th, 2026
GE HealthCare integrates bkActiv ultrasound with Medtronic Stealth AXiS for real-time cranial surgery navigation

GE HealthCare has announced a digital integration between its bkActiv intraoperative ultrasound system and Medtronic's Stealth AXiS surgical navigation system, now commercially available for cranial procedures. The integration allows neurosurgeons to use bkActiv as a plug-and-play real-time visualisation solution during procedures. The system addresses "brain shift", a natural movement of the brain during surgery that reduces pre-surgical image accuracy. bkActiv provides live ultrasound images alongside pre-operative MRI or CT scans on the Stealth AXiS system, recently cleared by the FDA for cranial procedures in the United States. Features include sterilisable transducers, sensitive colour Doppler for blood flow visualisation, and remote control capability from the sterile field. The companies will showcase the integration at the American Association of Neurological Surgeons Annual Scientific Meeting in May 2026.

Business Wire
Mar 25th, 2026
GE HealthCare unveils photon-counting CT and ReadyFix fleet management at ACC.26

GE HealthCare is showcasing its cardiology portfolio at ACC.26, featuring AI-enabled imaging technologies and software solutions addressing cardiovascular disease, which kills over 900,000 Americans annually. The company received US FDA 510(k) clearance for Photonova Spectra, a photon-counting CT system with proprietary Deep Silicon detectors designed to provide ultra-high-definition cardiac imaging and improved plaque characterisation. GE HealthCare introduced ReadyFix fleet management solution for MAC VU360 ECG workstations, enabling remote diagnostics and software deployment to optimise device uptime. The company also announced a US collaboration with Gentuity, connecting customers with HF-OCT and Vis-Rx PRIME Micro-Imaging Catheter for enhanced coronary procedure visualisation. The $20.6 billion company serves patients globally with imaging, diagnostics and AI solutions across the cardiology care pathway.

Business Wire
Mar 23rd, 2026
GE HealthCare's photon-counting CT Photonova Spectra receives FDA clearance

GE HealthCare has received FDA 510(k) clearance for Photonova Spectra, a photon-counting computed tomography system powered by its Deep Silicon detector technology. The system directly counts individual photons and measures their energy, enabling higher spectral and spatial resolution compared to conventional CT systems that first convert X-rays into visible light. Photonova Spectra features 8-bin energy resolution, wide detector coverage and rapid 0.23-second rotation speed, supporting fast acquisition and detailed visualisation across multiple clinical specialties. The system automatically captures spectral and ultra-high definition spatial data simultaneously without requiring special protocols. The technology incorporates NVIDIA accelerated computing to process up to 50 times more data than conventional CT systems. GE HealthCare is collaborating with institutions including UW-Madison and Stanford Medicine to explore clinical applications and imaging protocols.

Yahoo Finance
Mar 17th, 2026
GE HealthCare appoints Stryker CEO Kevin Lobo to board of directors

GE HealthCare has appointed Kevin Lobo, chair and CEO of Stryker Corporation, to its board of directors effective 13 March. Lobo brings over 25 years of medical technology, operational and financial leadership experience to the role. Lobo has served as Stryker's CEO since October 2012 and board chair since July 2014. Previously, he held leadership positions at Johnson & Johnson, including president of Ethicon Endo Strategy, and at chemical and pharmaceutical company Rhône-Poulenc. His early career included finance roles at KPMG, Unilever and Kraft Canada. GE HealthCare chairman H. Lawrence Culp said Lobo's clinical expertise and track record of driving innovation would strengthen the board as the company pursues growth priorities in personalised, connected healthcare.

Yahoo Finance
Mar 16th, 2026
Arthur J. Gallagher leads with 17.9% revenue growth while Grand Canyon Education and GE HealthCare struggle

Arthur J. Gallagher, an insurance brokerage and consulting firm, stands out amongst cash-producing stocks with a 12.8% trailing 12-month free cash flow margin. The company has demonstrated strong revenue growth of 17.9% annually over the past two years and earnings per share growth of 17.7% annually over five years, outperforming peers. In contrast, Grand Canyon Education faces challenges with underwhelming student numbers and modest earnings growth of just 7.2% annually over five years, despite a 21.6% free cash flow margin. GE HealthCare also struggles with weak 2.7% annual revenue growth over two years and limited organic expansion. Arthur J. Gallagher, operating in approximately 130 countries, provides insurance brokerage, reinsurance and consulting services globally.

INACTIVE